Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313377522> ?p ?o ?g. }
- W4313377522 endingPage "122490" @default.
- W4313377522 startingPage "122490" @default.
- W4313377522 abstract "The immunogenicity risk of therapeutic protein aggregates has been extensively investigated over the past decades. While it is established that not all aggregates are equally immunogenic, the specific aggregate characteristics, which are most likely to induce an immune response, remain ambiguous. The aim of this study was to perform comprehensive in vitro and in vivo immunogenicity assessment of human insulin aggregates varying in size, structure and chemical modifications, while keeping other morphological characteristics constant. We found that flexible aggregates with highly altered secondary structure were most immunogenic in all setups, while compact aggregates with native-like structure were found to be immunogenic primarily in vivo. Moreover, sub-visible (1-100 µm) aggregates were found to be more immunogenic than sub-micron (0.1-1 µm) aggregates, while chemical modifications (deamidation, ethylation and covalent dimers) were not found to have any measurable impact on immunogenicity. The findings highlight the importance of utilizing aggregates varying in few characteristics for assessment of immunogenicity risk of specific morphological features and may provide a workflow for reliable particle analysis in biotherapeutics." @default.
- W4313377522 created "2023-01-06" @default.
- W4313377522 creator A5000193287 @default.
- W4313377522 creator A5010054439 @default.
- W4313377522 creator A5019817687 @default.
- W4313377522 creator A5025644697 @default.
- W4313377522 creator A5031708632 @default.
- W4313377522 creator A5036520292 @default.
- W4313377522 creator A5040804836 @default.
- W4313377522 creator A5044989809 @default.
- W4313377522 creator A5060154290 @default.
- W4313377522 creator A5079620567 @default.
- W4313377522 date "2023-01-01" @default.
- W4313377522 modified "2023-10-18" @default.
- W4313377522 title "In vitro and in vivo immunogenicity assessment of protein aggregate characteristics" @default.
- W4313377522 cites W155302766 @default.
- W4313377522 cites W1970574672 @default.
- W4313377522 cites W1973555453 @default.
- W4313377522 cites W1976056766 @default.
- W4313377522 cites W1977357831 @default.
- W4313377522 cites W1985563555 @default.
- W4313377522 cites W1988718462 @default.
- W4313377522 cites W1993511309 @default.
- W4313377522 cites W1995725805 @default.
- W4313377522 cites W1999856601 @default.
- W4313377522 cites W2004774375 @default.
- W4313377522 cites W2011684044 @default.
- W4313377522 cites W2012557883 @default.
- W4313377522 cites W2025687917 @default.
- W4313377522 cites W2029174947 @default.
- W4313377522 cites W2030967651 @default.
- W4313377522 cites W2037512225 @default.
- W4313377522 cites W2048049691 @default.
- W4313377522 cites W2048087821 @default.
- W4313377522 cites W2049732297 @default.
- W4313377522 cites W2056085522 @default.
- W4313377522 cites W2060422244 @default.
- W4313377522 cites W2060874457 @default.
- W4313377522 cites W2061357129 @default.
- W4313377522 cites W2071095038 @default.
- W4313377522 cites W2078172351 @default.
- W4313377522 cites W2085024221 @default.
- W4313377522 cites W2102818896 @default.
- W4313377522 cites W2104000266 @default.
- W4313377522 cites W2111877521 @default.
- W4313377522 cites W2113093880 @default.
- W4313377522 cites W2125644345 @default.
- W4313377522 cites W2139232882 @default.
- W4313377522 cites W2151737415 @default.
- W4313377522 cites W2157754662 @default.
- W4313377522 cites W2165068832 @default.
- W4313377522 cites W2252698077 @default.
- W4313377522 cites W2281597363 @default.
- W4313377522 cites W2319662570 @default.
- W4313377522 cites W2331828703 @default.
- W4313377522 cites W2407597685 @default.
- W4313377522 cites W2481068577 @default.
- W4313377522 cites W2588013766 @default.
- W4313377522 cites W2619197807 @default.
- W4313377522 cites W2753400018 @default.
- W4313377522 cites W2872728035 @default.
- W4313377522 cites W2892339097 @default.
- W4313377522 cites W2898192685 @default.
- W4313377522 cites W2907438831 @default.
- W4313377522 cites W2926267620 @default.
- W4313377522 cites W2945385503 @default.
- W4313377522 cites W2983382335 @default.
- W4313377522 cites W2985494309 @default.
- W4313377522 cites W3014541697 @default.
- W4313377522 cites W4294002012 @default.
- W4313377522 cites W4295102969 @default.
- W4313377522 doi "https://doi.org/10.1016/j.ijpharm.2022.122490" @default.
- W4313377522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36521637" @default.
- W4313377522 hasPublicationYear "2023" @default.
- W4313377522 type Work @default.
- W4313377522 citedByCount "2" @default.
- W4313377522 countsByYear W43133775222023 @default.
- W4313377522 crossrefType "journal-article" @default.
- W4313377522 hasAuthorship W4313377522A5000193287 @default.
- W4313377522 hasAuthorship W4313377522A5010054439 @default.
- W4313377522 hasAuthorship W4313377522A5019817687 @default.
- W4313377522 hasAuthorship W4313377522A5025644697 @default.
- W4313377522 hasAuthorship W4313377522A5031708632 @default.
- W4313377522 hasAuthorship W4313377522A5036520292 @default.
- W4313377522 hasAuthorship W4313377522A5040804836 @default.
- W4313377522 hasAuthorship W4313377522A5044989809 @default.
- W4313377522 hasAuthorship W4313377522A5060154290 @default.
- W4313377522 hasAuthorship W4313377522A5079620567 @default.
- W4313377522 hasBestOaLocation W43133775221 @default.
- W4313377522 hasConcept C12554922 @default.
- W4313377522 hasConcept C136238340 @default.
- W4313377522 hasConcept C150903083 @default.
- W4313377522 hasConcept C171250308 @default.
- W4313377522 hasConcept C181199279 @default.
- W4313377522 hasConcept C185592680 @default.
- W4313377522 hasConcept C192562407 @default.
- W4313377522 hasConcept C202751555 @default.
- W4313377522 hasConcept C203014093 @default.